← Leaderboards
Amanda Guidon
Biosensics, Llc
$757,315
Attributed
$1,514,629
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $973.9K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,514,629 · 1
By mechanism
R44$1,514,629 · 1
Top collaborators
- Ashkan Vaziri3 shared
Others in their field
Other Rising Stars on “Effective Therapy”
- Supriya Menezes · The Emmes Company, Llc$18,394,958
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Maximilian Haeussler · University Of California Santa Cruz$12,592,563
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
Effective TherapyGeneral HospitalsComplementDysarthriaFaceFundingActivities Of Daily LivingCommon SymptomConsumptionData ExchangeEfficacy EvaluationBiological MarkersBiomarker DiscoveryCaringCharacteristicsChronicClinicClinical TrialsAutoimmuneClinical PhenotypeClinical ResearchCostClinical Trial ReadinessHealth Insurance Portability And Accountability Act
Grant awards (3)
Wearable Sensor and Digital Technologies for Quantitative Assessment and Remote Monitoring of Symptoms in Myasthenia Gravis$973,917
R44 · FY2025 · NS
Wearable Sensor and Digital Technologies for Quantitative Assessment and Remote Monitoring of Symptoms in Myasthenia Gravis$40,712
R44 · FY2023 · NS
Wearable Sensor and Digital Technologies for Quantitative Assessment and Remote Monitoring of Symptoms in Myasthenia Gravis$500,000
R44 · FY2022 · NS